Brian K Irons

Summary

Affiliation: Texas Tech University Health Sciences Center
Country: USA

Publications

  1. ncbi request reprint Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus
    Brian K Irons
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, Department of Pharmacy Practice, Lubbock, TX, USA
    J Cardiovasc Pharmacol Ther 18:427-32. 2013
  2. ncbi request reprint An update in incretin-based therapy: a focus on dipeptidyl peptidase--4 inhibitors
    Brian K Irons
    Ambulatory Care Texas Tech University Health Sciences Center, School of Pharmacy, 3601 4th St Lubbock, TX 79430, USA
    Curr Diabetes Rev 8:169-82. 2012
  3. doi request reprint Evaluation of diabetes primary care and effects on health care charges in elderly patients with diabeties
    Brian K Irons
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center, Lubbock, Texas 79430 8162, USA
    Am J Med Sci 335:426-30. 2008
  4. ncbi request reprint Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79430 8162, USA
    Pharmacotherapy 26:168-81. 2006
  5. ncbi request reprint Lipid management with statins in type 2 diabetes mellitus
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX 79430 8162, USA
    Ann Pharmacother 39:1714-9. 2005
  6. ncbi request reprint The use of angiotensin receptor blockers in the treatment of chronic heart failure
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, Texas 79430 8162, USA
    J Cardiovasc Pharmacol 44:718-24. 2004
  7. ncbi request reprint Delaying the onset of type 2 diabetes mellitus in patients with prediabetes
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX 79430 8162, USA
    Pharmacotherapy 24:362-71. 2004
  8. ncbi request reprint Valsartan-induced angioedema
    Brian K Irons
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy Lubbock Programs, Lubbock, TX, USA
    Ann Pharmacother 37:1024-7. 2003
  9. doi request reprint Quality of care of a pharmacist-managed diabetes service compared to usual care in an indigent clinic
    Brian K Irons
    School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX 79430 8162, USA
    Diabetes Technol Ther 10:220-6. 2008
  10. ncbi request reprint Planning and implementing an interdisciplinary diabetes workshop for healthcare professionals
    Gloria M Valdez
    Nursing Faculty, Covenant School of Nursing, Lubbock, Texas, USA
    J Contin Educ Nurs 38:232-7. 2007

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus
    Brian K Irons
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, Department of Pharmacy Practice, Lubbock, TX, USA
    J Cardiovasc Pharmacol Ther 18:427-32. 2013
    ....
  2. ncbi request reprint An update in incretin-based therapy: a focus on dipeptidyl peptidase--4 inhibitors
    Brian K Irons
    Ambulatory Care Texas Tech University Health Sciences Center, School of Pharmacy, 3601 4th St Lubbock, TX 79430, USA
    Curr Diabetes Rev 8:169-82. 2012
    ..For patients with mildly elevated glucose concentrations, they are therapeutic options in both drug-naive patients as well as those not optimally controlled on other diabetes medications...
  3. doi request reprint Evaluation of diabetes primary care and effects on health care charges in elderly patients with diabeties
    Brian K Irons
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center, Lubbock, Texas 79430 8162, USA
    Am J Med Sci 335:426-30. 2008
    ..This study assessed diabetes out-patient care at a single institution in Medicare patients with significant health care expenditures and correlated the control of these patients with hospital admission rates and charges...
  4. ncbi request reprint Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79430 8162, USA
    Pharmacotherapy 26:168-81. 2006
    ..Alterations in these risk factors are likely due to their effects on improving insulin sensitivity and/or glycemic control. Trials to assess whether thiazolidinediones actually reduce cardiovascular outcomes are continuing...
  5. ncbi request reprint Lipid management with statins in type 2 diabetes mellitus
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX 79430 8162, USA
    Ann Pharmacother 39:1714-9. 2005
    ..To provide an update on lipid management and recent modifications in cholesterol guidelines for use of hydroxymethylglutaryl coenzyme A reductase inhibitors (statins), specifically in patients with diabetes...
  6. ncbi request reprint The use of angiotensin receptor blockers in the treatment of chronic heart failure
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, Texas 79430 8162, USA
    J Cardiovasc Pharmacol 44:718-24. 2004
    ..In patients with heart failure but preserved systolic dysfunction, candesartan showed no effects on mortality and only modest effects on morbidity...
  7. ncbi request reprint Delaying the onset of type 2 diabetes mellitus in patients with prediabetes
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX 79430 8162, USA
    Pharmacotherapy 24:362-71. 2004
    ..Pharmacists can promote awareness, counsel patients on intervention strategies to delay the onset of diabetes mellitus, and screen high-risk patients...
  8. ncbi request reprint Valsartan-induced angioedema
    Brian K Irons
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy Lubbock Programs, Lubbock, TX, USA
    Ann Pharmacother 37:1024-7. 2003
    ..To report a case of dose-dependent angioedema secondary to the use of the angiotensin-receptor blocker (ARB) valsartan...
  9. doi request reprint Quality of care of a pharmacist-managed diabetes service compared to usual care in an indigent clinic
    Brian K Irons
    School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX 79430 8162, USA
    Diabetes Technol Ther 10:220-6. 2008
    ..This study evaluates the quality of care of a pharmacist-managed diabetes clinic focused on an indigent population and compares that quality of care to usual care in the same health care setting...
  10. ncbi request reprint Planning and implementing an interdisciplinary diabetes workshop for healthcare professionals
    Gloria M Valdez
    Nursing Faculty, Covenant School of Nursing, Lubbock, Texas, USA
    J Contin Educ Nurs 38:232-7. 2007
    ..The lessons learned during this project are provided for consideration by others seeking to address common concerns and challenges in other areas of clinical practice...
  11. ncbi request reprint Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers
    Timothy A Mazzolini
    Department of Veterans Affairs, Lubbock VA Outpatient Clinic, Lubbock, TX 79412, USA
    J Manag Care Pharm 11:763-71. 2005
    ....
  12. ncbi request reprint An update in incretin-based therapy: a focus on glucagon-like peptide-1 receptor agonists
    Krystal L Edwards
    School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, Texas 75216, USA
    Diabetes Technol Ther 14:951-67. 2012
    ..For T2DM patients willing to use an injectable agent, exenatide and liraglutide offer another therapeutic option to control hyperglycemia with the potential for weight loss and may be combined with other agents safely...
  13. doi request reprint Third-line agent selection for patients with type 2 diabetes mellitus uncontrolled with sulfonylureas and metformin
    Krystal L Edwards
    School of Pharmacy, Texas Tech University Health Sciences Center, Department of Pharmacy Practice, Veterans Administration North Texas Health Care System, Dallas, TX 75216, USA
    Pharmacotherapy 28:506-21. 2008
    ..Therefore, a standard of care cannot be provided; rather, clinicians must evaluate each patient to ascertain that patient's optimum therapy. In doing so, clinicians need to be familiar with the efficacy, safety, and cost of each agent...
  14. doi request reprint Factors associated with increased hospital utilization in patients with heart failure and preserved ejection fraction
    Rachel S Crowder
    University Medical Center, Texas Tech University Health Sciences Center, Lubbock, Texas 79430 8162, USA
    Pharmacotherapy 30:646-53. 2010
    ..To determine whether controlling systolic blood pressure (SBP), pulse pressure, and heart rate in the outpatient setting is associated with decreased hospital utilization in patients with heart failure and preserved ejection fraction (PEF)...
  15. ncbi request reprint Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals
    Kathleen A Snella
    School of Pharmacy, University of Missouri Kansas City, Columbia, MO 65211, USA
    J Am Pharm Assoc (2003) 46:370-7. 2006
    ..To assess a model to screen minority, elderly, and at-risk individuals for diabetes, hypertension, and dyslipidemia in pharmacy and non-health care settings...
  16. ncbi request reprint The need for a community diabetes education curriculum for healthcare professionals
    Brian K Irons
    School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA
    J Contin Educ Nurs 38:227-31. 2007
    ..Fifty-five of those participants stated a strong interest in pursuing certified diabetes educator certification, which may significantly increase the number of certified diabetes educators in both rural and urban areas of West Texas...
  17. ncbi request reprint A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic
    Brian K Irons
    Department of Pharmacy Practice, Texas Tech University Health Sciences Center School of Pharmacy, Amarillo, USA
    Pharmacotherapy 22:1294-300. 2002
    ..11 +/- 0.46, p = 0.003). Pharmacist-managed diabetes care was effective in improving glycemic control and was not associated with an increased risk for hypoglycemic events or unscheduled diabetes-related clinic visits...
  18. ncbi request reprint Removing barriers to insulin use
    Molly G Minze
    School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, USA
    J Fam Pract 60:577-80. 2011
    ..Patients with type 2 diabetes and their physicians are often reluctant to begin insulin therapy--despite evidence of its efficacy. Here's help in overcoming this other form of "insulin resistance."..
  19. ncbi request reprint Update on the management of dyslipidemia
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA
    Am J Health Syst Pharm 59:1615-25. 2002
    ..The updated guidelines recommend more intensive lipid-lowering treatments for primary prevention in patients with two or more risk factors...